Therapeutic Potentials of Itasetron (DAU 6215), a Novel 5-HT3Receptor Antagonist, in the Treatment of Central Nervous System Disorders

This publication has 76 references indexed in Scilit:

• Memory disorders: Novel treatments, clinical perspective
  Life Sciences, 1994
• Evaluation of the Bioequivalence of Tablet and Capsule Formulations of Granisetron in Patients Undergoing Cytotoxic Chemotherapy for Malignant Disease
  Journal of Pharmaceutical Sciences, 1993
• Tropisetron
  Drugs, 1993
• Cloning and fnctional expression of an apparent splice variant of the murine 5-HT3 receptor A subunit
  European Journal of Pharmacology: Molecular Pharmacology, 1993
• The Selective innervation by serotoninergic axons of calbindin‐containing interneurons in the neocortex and hippocampus of the marmoset
  Journal of Comparative Neurology, 1992
• Recent advances in the electrophysiological characterization of 5-HT3 receptors
  Trends in Pharmacological Sciences, 1992
• Granisetron
  Drugs, 1991
• Ondansetron
  Drugs, 1991
• Normal densities of 5-HT3 receptor recognition sites in Alzheimerʼs disease
  NeuroReport, 1990
• Spatial localization does not require the presence of local cues
  Learning and Motivation, 1981